Moxicip Lp Eye Drops 5Ml

Moxicip Lp Eye Drops are used to manage bacterial eye infections and to help prevent infection after eye surgery.

Uses of Moxicip Lp Eye Drops are:

• Bacterial Eye Infections: Treats bacterial eye infections that occur with inflammation.
• Eye Inflammation: Helps reduce eye redness, swelling and irritation.
• Post-surgical Infection Prevention: Helps prevent bacterial infection after eye surgery.

To use Moxicip Lp Eye Drops 5ml, follow these steps:

• Shake the bottle well before each use.
• Instil one or two drops into the pouch formed by pulling down your lower eyelid.
• Avoid touching your eye or any other surface with the dropper to prevent contamination.
• Repeat this process for your other eye if advised by your doctor.
• For precise dosage instructions and duration of use, it's best to consult your doctor.

Moxicip Lp Eye Drops 5ml are instilled topically.

Moxicip Lp Eye Drops 5ml is a combination medicine with the following active ingredients: 

• Loteprednol (0.5 %): Loteprednol is a corticosteroid. It reduces swelling and inflammation in the eyes by suppressing the body's immune response and inhibiting pro-inflammatory signals, thus reducing redness and pain that can occur with eye infections.
• Moxifloxacin (0.5 %): Moxifloxacin, a fluoroquinolone antibiotic, kills bacteria by interfering with the enzymes that cause DNA to rewind after being copied, which stops DNA replication and repair in bacterial cells, thus causing them to die.

• Store your Moxicip Lp Eye Drops 5ml upright, in a cool place, not exceeding 30°C.
• Keep it away from direct sunlight, heat, and moisture.
• Always remember to keep medicines out of reach for children.

• Ensure personal hygiene to prevent the spread of infection; wash hands before and after applying eye or ear drops.
• Use separate towels and washcloths to avoid contaminating other areas or other people.
• Avoid touching the tip of the dropper to any surface, including fingers, eyes or ears.
• Maintain adequate hydration, especially if you are experiencing mild systemic symptoms post-application.